Cost-effectiveness of drotrecogin alfa (activated) in the treatment of severe sepsis* - Concepedia

Concepedia

Publication | Closed Access

Cost-effectiveness of drotrecogin alfa (activated) in the treatment of severe sepsis*

226

Citations

36

References

2003

Year

Derek C. Angus, Walter T. Linde‐Zwirble, Gilles Clermont, Daniel Ball, Bruce R. Basson, E. Wesley Ely, Pierre‐François Laterre, Jean‐Louis Vincent, Gordon R. Bernard, Ben van Hout

Critical Care Medicine

Abstract

Drotrecogin alfa has a cost-effectiveness profile similar to that of many well-accepted healthcare strategies and below commonly quoted thresholds.

References

	Year	Citations

Page 1